OBJECTIVES: Many patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) experience a delay in treatment or fail to initiate treatment with guideline-recommended angiotensin-converting ...

Angiotensin-converting enzyme (ACE) inhibitors are the mainstay of therapy for patients with systemic sclerosis in scleroderma renal crisis, however mortality remains high even in the post-ACE ...

Researchers recently reported a preliminary signal of possible structural damage in the kidneys of six patients after long-term treatment with a renin-angiotensin system (RAS) inhibitor, a superclass ...

In the US, 20–40% of patients with diabetes develop diabetic nephropathy, half of whom will experience progression to end-stage renal disease (ESRD). Despite the extensive use of ...

Treatment with an angiotensin-converting enzyme (ACE) inhibitor/angiotensin receptor blocker and sodium-glucose cotransporter-2 (SGLT2) inhibitor combination demonstrated better outcomes in kidney ...

For young patients with the kidney disease IgA nephropathy (IgAN), early treatment with angiotensin-converting enzyme (ACE) inhibitors can reduce the long-term risk of irreversible kidney damage, ...

Dr. Butler answers the question: 'Side Effects Of ACE Inhibitors?' — -- Question: What are the benefits and side effects of ACE Inhibitors? Answer: There are a lot of benefits to ACE inhibitor ...

Dr. Butler answers the question: 'What Is An ACE Inhibitor?' — -- Question: What is an ACE inhibitor, how does it work, and when is it used to treat heart failure? Answer: ACE inhibitors are very ...

Angiotensin-converting enzyme (ACE) inhibitors are oral medications that lower blood pressure. They are used to treat a ...